Innate Pharma (IPHA) — Free Cash Flow Generation Index
Latest as of June 2024:
0.91x
Innate Pharma (IPHA) has a Free Cash Flow Generation Index of 0.91x as of June 2024. Free cash flow of $2.75 Million represents 1% of operating cash flow ($3.04 Million). Explore IPHA capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.91x
Free Cash Flow / Operating CF
Free Cash Flow
$2.75 Million
USD
Operating Cash Flow
$3.04 Million
USD
Capital Expenditures
$283.00K
USD
Innate Pharma Free Cash Flow Generation Index (2006–2019)
Historical FCF Generation Index trend for Innate Pharma across 4 annual periods. For the full cash flow conversion analysis, see IPHA cash flow conversion.
Annual Free Cash Flow Generation for Innate Pharma (2006–2019)
Year-by-year Free Cash Flow Generation Index for Innate Pharma. Check Innate Pharma (IPHA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | -0.87x | $-30.48 Million | $34.92 Million | $65.40 Million | ▼ -190.5% |
| 2015 | 0.96x | $200.51 Million | $207.91 Million | $7.40 Million | ▼ -1.1% |
| 2011 | 0.98x | $12.66 Million | $12.99 Million | $322.00K | ▲ +189.6% |
| 2006 | -1.09x | $-392.00K | $360.00K | $752.00K | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).